152 related articles for article (PubMed ID: 22447917)
21. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
22. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
23. Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis.
Sun W; Guo MM; Han P; Lin JZ; Liang FY; Tan GM; Li HB; Zeng M; Huang XM
Carcinogenesis; 2012 Apr; 33(4):810-7. PubMed ID: 22301282
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
25. Long-term treatment results of invasive cervical cancer patients undergoing inadvertent hysterectomy followed by salvage radiotherapy.
Hsu WL; Shueng PW; Jen YM; Wu CJ; Hwang JM; Chang LP; Chen CM; Lin LC; Teh BS
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):521-7. PubMed ID: 15145172
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma.
Paley PJ; Goff BA; Minudri R; Greer BE; Tamimi HK; Koh WJ
Gynecol Oncol; 2000 Mar; 76(3):373-9. PubMed ID: 10684713
[TBL] [Abstract][Full Text] [Related]
29. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
Distefano M; Ferrandina G; Smaniotto D; Margariti AP; Zannoni G; Macchia G; Manfredi R; Mangiacotti MG; Cellini N; Scambia G
Oncology; 2004; 67(2):103-11. PubMed ID: 15539913
[TBL] [Abstract][Full Text] [Related]
30. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer.
Fradet V; Lessard L; Bégin LR; Karakiewicz P; Masson AM; Saad F
Clin Cancer Res; 2004 Dec; 10(24):8460-4. PubMed ID: 15623625
[TBL] [Abstract][Full Text] [Related]
32. Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma.
Yamanaka N; Sasaki N; Tasaki A; Nakashima H; Kubo M; Morisaki T; Noshiro H; Yao T; Tsuneyoshi M; Tanaka M; Katano M
Anticancer Res; 2004; 24(2C):1071-5. PubMed ID: 15154625
[TBL] [Abstract][Full Text] [Related]
33. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.
Sasaki N; Morisaki T; Hashizume K; Yao T; Tsuneyoshi M; Noshiro H; Nakamura K; Yamanaka T; Uchiyama A; Tanaka M; Katano M
Clin Cancer Res; 2001 Dec; 7(12):4136-42. PubMed ID: 11751513
[TBL] [Abstract][Full Text] [Related]
34. A correlative study of NF-kappaB activity and cytokines expression in human chronic nasal sinusitis.
Xu R; Xu G; Shi J; Wen W
J Laryngol Otol; 2007 Jul; 121(7):644-9. PubMed ID: 17040605
[TBL] [Abstract][Full Text] [Related]
35. [Expression of nuclear factor-kappa-B/P65 and fragile histidine triad in colorectal carcinoma and clinical significance thereof].
Lü Y; Liu L; Zhao P
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):610-4. PubMed ID: 18646716
[TBL] [Abstract][Full Text] [Related]
36. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
37. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
38. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma.
Azria E; Morice P; Haie-Meder C; Thoury A; Pautier P; Lhomme C; Duvillard P; Castaigne D
Ann Surg Oncol; 2005 Apr; 12(4):332-7. PubMed ID: 15827678
[TBL] [Abstract][Full Text] [Related]
39. [Combined treatment for locally advanced carcinoma of uterine cervix].
Wang Y; Cao P; Zhang X; Zeng Q
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):508-10. PubMed ID: 12485512
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of nuclear factor κB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis.
Wu Z; Peng X; Li J; Zhang Y; Hu L
Int J Gynecol Cancer; 2013 Jun; 23(5):906-15. PubMed ID: 23640294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
